Hypoxia Induced Ocular Neovascularization Model
Hypoxia Induced Ocular Neovascularization Model
批准号:
6786541
负责人:
WEN L SENG
金额:
$17.27万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-01 至 2005-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant) The leading cause of blindness in adults is diabetic retinopathy and age-related macular degeneration. Both conditions involve vascular abnormalities, leakage and proliferation of new blood vessels. Retinopathy of prematurity is a major cause of newborn blindness in premature infants maintained by oxygen supplementation during the postnatal period. This condition involves intense neovascularization of the retina and leads to retinal detachment. Another cause of blindness is corneal neovascularization, which often results from injury and infection in the cornea. Current mammalian ocular neovascularization models for screening potential therapeutics require tedious surgical manipulation and are lengthy. Using zebrafish embryos, this SBIR proposes to develop a hypoxia induced zebrafish ocular neovascularization model. Zebrafish is a good animal model for eye disease. Orthologs of many genes involved in angiogenesis in mammals have been identified in zebrafish. Assays and drug treatment are easily performed on the zebrafish embryo because of its rapid ex-utero development. Embryos are transparent, permitting visual observation of defects in development and angiogenesis in the eye and elsewhere. This SBIR will characterize embryogenesis and patterning, and blood vessel formation in the zebrafish eye. This SBIR will also confirm expression of hypoxia-induced genes in zebrafish. The zebrafish model will facilitate screening and development of therapeutics for eye diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Device for Automating Zebrafish Processing
-
批准号:8258245
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2011
-
负责人:WEN L SENG
-
依托单位:
New Whole Animal ELISA for Angiogenic Drug Screening
-
批准号:7541282
-
项目类别:
-
资助金额:$13.52万
-
财政年份:2008
-
负责人:WEN L SENG
-
依托单位:
Zebrafish Wound Healing Model for Drug Screening
-
批准号:7052495
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2006
-
负责人:WEN L SENG
-
依托单位:
In Vivo Ocular Angiogenesis Assay
-
批准号:7500157
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2005
-
负责人:WEN L SENG
-
依托单位:
In Vivo Ocular Angiogenesis Assay
-
批准号:7687368
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2005
-
负责人:WEN L SENG
-
依托单位:
In Vivo Ocular Angiogenesis Assay
-
批准号:7218516
-
项目类别:
-
资助金额:$20.2万
-
财政年份:2005
-
负责人:WEN L SENG
-
依托单位:
In Vivo Ocular Angiogenesis Assay
-
批准号:7847850
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2005
-
负责人:WEN L SENG
-
依托单位:
A New Model for Eye Disease
-
批准号:7290925
-
项目类别:
-
资助金额:$15.82万
-
财政年份:2004
-
负责人:WEN L SENG
-
依托单位:
A New Model for Eye Disease
-
批准号:7848688
-
项目类别:
-
资助金额:$2.46万
-
财政年份:2004
-
负责人:WEN L SENG
-
依托单位:
A New Model for Eye Disease
-
批准号:7123334
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2004
-
负责人:WEN L SENG
-
依托单位:
Whole Animal ELISA for Liver Toxicity
-
批准号:6547143
-
项目类别:
-
资助金额:$18.58万
-
财政年份:2002
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Microplate Assay for Toxicity Screening
-
批准号:6409916
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2001
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Angiogenesis ELISA for Drug Screening
-
批准号:6406843
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2001
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Microplate Assay for Angiogenesis
-
批准号:6552588
-
项目类别:
-
资助金额:$57.78万
-
财政年份:2001
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Microplate Assay for Angiogenesis
-
批准号:6644157
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2001
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Microplate Assay for Angiogenesis
-
批准号:6756615
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2001
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Assay for Angiogenesis Inhibition
-
批准号:6748927
-
项目类别:
-
资助金额:$17.66万
-
财政年份:2000
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Assay for Angiogenesis Inhibition
-
批准号:6622501
-
项目类别:
-
资助金额:$34.41万
-
财政年份:2000
-
负责人:WEN L SENG
-
依托单位:
Whole Animal Assay for Angiogenesis Inhibition
-
批准号:6448312
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2000
-
负责人:WEN L SENG
-
依托单位: